People | Locations | Statistics |
---|---|---|
Naji, M. |
| |
Motta, Antonella |
| |
Aletan, Dirar |
| |
Mohamed, Tarek |
| |
Ertürk, Emre |
| |
Taccardi, Nicola |
| |
Kononenko, Denys |
| |
Petrov, R. H. | Madrid |
|
Alshaaer, Mazen | Brussels |
|
Bih, L. |
| |
Casati, R. |
| |
Muller, Hermance |
| |
Kočí, Jan | Prague |
|
Šuljagić, Marija |
| |
Kalteremidou, Kalliopi-Artemi | Brussels |
|
Azam, Siraj |
| |
Ospanova, Alyiya |
| |
Blanpain, Bart |
| |
Ali, M. A. |
| |
Popa, V. |
| |
Rančić, M. |
| |
Ollier, Nadège |
| |
Azevedo, Nuno Monteiro |
| |
Landes, Michael |
| |
Rignanese, Gian-Marco |
|
Angelova, Angelina
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (2/2 displayed)
Places of action
Organizations | Location | People |
---|
article
Pep-Lipid Cubosomes and Vesicles Compartmentalized by Micelles from Self-Assembly of Multiple Neuroprotective Building Blocks Including a Large Peptide Hormone PACAP-DHA
Abstract
Structural control over design and formation of selfassembled nanomaterials for neuroprotection and neuroregeneration is crucial for their application in nanomedicine. Here a synthetic construct of the pituitary adenylate cyclase-activating polypeptide (PACAP38) coupled to a docosahexaenoic acid (DHA: an ω-3 polyunsaturated fatty acid (PUFA)) is designed towards the creation of compartmentalized liquid crystalline assemblies of neuroprotective compounds. The hormone PACAP38 is a ligand of the class B PAC1 G-protein-coupled receptor (GPCR), whereas DHA is a lipid trophic factor. The lipidated peptide PACAP-DHA is co-assembled into hierarchical nanostructures elaborated from hybrid vesicle-micelle reservoirs as well into PEGylated cubosomes composed of multiple neuroprotective building blocks. The resulting nanostructures are determined by synchrotron small-angle X-ray scattering (BioSAXS) and cryogenic transmission electron microscopy (cryo-TEM). Multicompartment topologies are obtained in a twofold approach: (i) intriguing compartmentalized vesicles, which embed pep-lipid micelles forming nanopatterns, and (ii) multidomain pep-lipid cubosomes. Both kinds of topologies are favorable for sustainedrelease applications in combination therapies of neurodegeneration. The organizational complexity of the scaffolds involving the lipidated high-molecular weight peptide hormone is beyond the one that has been reached with small lipid-like peptide surfactants.